From stay-at-home mom to science extraordinaire—spend the day with Process Technician Apprentice, Dianna Gordon at Amgen Ohio. Happy Mother's Day!
About us
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. See our Community Guidelines: bit.ly/smcgl See our Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.
- Website
-
http://www.amgen.com
External link for Amgen
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Thousand Oaks, CA
- Type
- Public Company
- Founded
- 1980
- Specialties
- Biologics, Human therapeutics, and Development of novel products
Locations
Employees at Amgen
Updates
-
Of the estimated 10 million Americans with #osteoporosis, a staggering 8 million are women. Today’s Bone Health Panel at the Hearst Health Lab underscores the importance of empowering women to reshape this narrative. With a longstanding legacy in osteoporosis research and treatment, Amgen is committed to supporting women in their journey of managing postmenopausal osteoporosis. Thank you, Dr. Kristi Tough DeSapri, MD, NCMP, CCD, ONEYOGAHOUSE Founder & CEO Anna Haddad, patient advocate Laura, and Hearst Editorial Director jane francisco for coming together to explore how women can take control of their bone health during Osteoporosis Month and beyond. #AmgenSponsored #HearstHealthLab
-
Before supporting the health of others, our benefits empower you to take care of and enhance your own health. Amgen resources give you everything you need—and more—to support yourself and your family. Learn more: https://bit.ly/3Hpvyus
-
We are honored to report that Amgen has been ranked #1 among 15 pharmaceutical peers in overall corporate reputation among U.S. groups familiar with us in PatientView's 2023 'Corporate Reputation of Pharma' survey. Patient communities play a vital role in shaping our work, and we’re excited to be making a positive impact in meeting their needs. 🔗 Learn more about what these patient groups have to say about the pharmaceutical industry as a whole: https://lnkd.in/dhzjjyfG
-
Está aberta a Consulta Pública nº 20/2024 sobre a incorporação de um medicamento para pacientes com Distúrbio do Espectro da Neuromielite Óptica (DENMO) positivos para o anticorpo anti-aquaporina 4.¹ As contribuições podem ser feitas entre os dias 09 e 28 de maio de 2024, pelo site https://lnkd.in/dmK-fZc. Compartilhe esta informação para que mais pessoas tenham conhecimento desta iniciativa, tendo em vista que a Consulta Pública é uma oportunidade de participar da construção da política pública em saúde do país² e toda contribuição é importante! Acesse também por meio do link abaixo e compartilhe esse conteúdo para que possamos juntos transformar a vida de pacientes com DENMO. https://lnkd.in/gBUqpAfg Referências: Participa + Brasil: Consulta Pública Conitec/SECTICS nº 20/2024 - Inebilizumabe para o tratamento de pacientes com distúrbio do espectro da neuromielite óptica positivos para o anticorpo anti-aquaporina 4. Disponível em: https://lnkd.in/gBUqpAfg. Acessado em: 08/05/2024. MINISTÉRIO DA SAÚDE. Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde – CONITEC. Disponível em: https://lnkd.in/dCfPwrE7. Acessado em 09/05/2024.
-
In our bold ambition to cut heart attacks and strokes in half by 2030, we draw inspiration from individuals like Aaron Holm, who confront heart disease with determination. After being diagnosed with high LDL ("bad") cholesterol and enduring open heart surgery, Aaron became the founder and president of his local Puget Sound chapter of The Mended Hearts, Inc.–a nonprofit organization providing support, education, and hope to people living with heart disease. Aaron's journey highlights the importance of community and the power of knowledge in working towards a healthier heart. On this #NationalLipidDay, we encourage everyone to take proactive steps to understand and manage their LDL cholesterol level. 🔗 Watch Aaron’s full story: https://amgen.ly/44Ahg4W
-
In honor of Asian American and Pacific Islander (AAPI) Heritage Month, we’re celebrating the contributions of our AAPI colleagues who enrich our global community. Calvin Chen, Executive Director, US Supply Chain, and Global Chair of our Amgen Asian Association (AAA) employee resource group, shares how his 17-year journey at Amgen inspires him to champion diversity, inclusion and belonging and empower us to deliver on our mission to better serve patients.
-
Amgen internships provide students and recent graduates great opportunities to build real-world experience while changing lives worldwide. Hear directly from our interns about their experiences and how you can launch your career with us: https://lnkd.in/e2xqP7wf
-
Two out of three women with postmenopausal osteoporosis at high risk for fracture will break a bone. Amgen is teaming up with Claire Gill, CEO of Bone Health & Osteoporosis Foundation (BHOF), to bring awareness to the unmet needs of those living with #osteoporosis. Our collaboration with organizations like BHOF is crucial in empowering patients, ensuring proper diagnosis, and providing innovative treatments. #OsteoporosisAwarenessMonth
-
“After my diagnosis, I found myself thinking about it regularly. How can you not? You’re suddenly confronted with, in a very real way, your mortality.” Otis Wilson Otis W., who works at Amgen as a senior oncology specialist based in Houston, gets personal about being diagnosed with multiple myeloma and how he balanced work, family and taking care of himself.